SCHEMBL3771977

SCHEMBL3771977

O=C(CN1CCC(O)(c2cccc(C(F)(F)F)c2)CC1)N1CCN(C2CCCC2)CC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 10/20 0.60
OPRM1 P35372 8/20 0.60
OPRK1 P41145 3/20 0.60
OPRD1 P41143 3/20 0.57
TRPV6 Q9H1D0 1/20 0.54
TRPV5 Q9NQA5 1/20 0.54
CHRM4 P08173 1/20 0.49
ABCB11 O95342 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
PKM P14618 1/20 0.49
TSHR P16473 1/20 0.49
MAPK1 P28482 1/20 0.49
THPO P40225 1/20 0.49
MTOR P42345 1/20 0.49
EBP Q15125 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
KDM4E B2RXH2 1/20 0.48
PMP22 Q01453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3772583 0.98 OPRL1 (0.58) OPRL1OPRM1OPRK1OPRD1TRPV6
SCHEMBL13005268 0.87 HTT (0.49) OPRL1OPRM1OPRK1OPRD1KDM4E
SCHEMBL13005270 0.85 ALDH1A1 (0.48) OPRL1OPRM1OPRK1OPRD1KDM4E
SCHEMBL3774342 0.85 NPSR1 (0.46) OPRL1OPRM1OPRK1OPRD1CYP2D6
SCHEMBL3772438 0.83 NPSR1 (0.44) OPRL1OPRM1OPRK1OPRD1CYP2D6
SCHEMBL3773978 0.81 POLB (0.60) SMN1; SMN2MEN1KMT2A
SCHEMBL3777229 0.80 KMT2A (0.60) OPRL1OPRM1OPRK1OPRD1TSHR
SCHEMBL3769985 0.80 POLB (0.59) SMN1; SMN2MEN1KMT2A
SCHEMBL3127147 0.79 MAPT (0.54) OPRL1OPRM1OPRK1CHRM4ABCB11
SCHEMBL3772549 0.79 MEN1 (0.64) CYP3A4CYP2D6SIGMAR1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
WO-2007016496-A2 DIPIPERAZINYL KETONES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 OPRL1 347/4885OPRM1 743/4885OPRK1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.